Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Chimeric-anti-interleukin-6 monoclonal antibody

EU orphan designation number: EU/3/09/642
Active ingredient: Chimeric-anti-interleukin-6 monoclonal antibody
Indication: Treatment of multiple myeloma
Sponsor: Janssen Biologics B.V.
Einsteinweg 101, NL-2333 CB Leiden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/06/2009 Centralised Orphan - Designation EMEA/OD/003/09 (2009)4682 of 12/06/2009
24/08/2011 Other procedure EMEA/OD/003/09
28/07/2014 Centralised Orphan - Removal of orphan designation from Community Register